ABSTRACT
PURPOSE: To evaluate the results of epithelium-off continuous light accelerated corneal cross-linking (CXL) with a total dose of 7.2 J/cm2 for treating progressive keratoconus in a Chinese population during 24 months of follow-up. METHODS: In this retrospective, interventional case series, 45 eyes of 31 consecutive patients with progressive keratoconus were evaluated. All patients underwent accelerated CXL with settings of 30 mW/cm2 for 4 minutes, corresponding to a total dose of 7.2 J/cm2. Visual acuity, manifest refraction, epithelial thickness, topography, tomography, aberrometry, endothelial cell count, and intraocular pressure were evaluated at baseline and at 1, 3, 6, 12, 18, and 24 months postoperatively. RESULTS: Progressive keratoconus was stabilized in 91.11% and 93.33% of the patients at 12 and 24 months, respectively. The improvement in corrected distance visual acuity was significant throughout the postoperative follow-up period (P < .05), excluding month 1. A significant decrease in the maximum keratometric values (0.67 ± 1.68, 0.92 ± 1.78, and 0.97 ± 1.73 D) was observed at months 12, 18, and 24, respectively (P < .05 for all). Corneal irregularity improved, particularly total root mean square and higher order aberrations at 12 to 24 months after CXL. In bilateral CXL, the progression of the first eye was highly predictive of the outcome of the second eye. CONCLUSIONS: CXL with a total dose of 7.2 J/cm2 maintains long-term results in halting the progression of keratoconus, with significant improvement in the corrected distance visual acuity and stability of keratometric values. Further clinical studies with longer follow-up periods and larger samples are necessary to confirm these results. [J Refract Surg. 2020;36(11):731-739.].
Subject(s)
Keratoconus , Photochemotherapy , China , Collagen/therapeutic use , Corneal Topography , Cross-Linking Reagents/therapeutic use , Epithelium , Humans , Keratoconus/drug therapy , Photosensitizing Agents/therapeutic use , Retrospective Studies , Riboflavin/therapeutic use , Ultraviolet RaysABSTRACT
Purpose: To analyze the clinical and regional distribution characteristics of obstructive meibomian gland dysfunction (OMGD) in China. Methods: A total of 2900 patients (2900 eyes) diagnosed with OMGD were enrolled in this multicenter, cross-sectional, observational study. The Ocular Surface Disease Index (OSDI), tear film breakup time (FBUT), Schirmer test (SI), lipid layer thickness (LLT), OMGD grade, meibomian gland loss score (Meiboscore), meibum expressibility score (MES), meibum quality score (MQS), Lid margin abnormality score(LMS) and other tear film stability markers were evaluated. Results: The prevalence of dry eye in OMGD patients was 89%. There were gender differences among OMGD patients in the 30-39 and 50-59 years age groups (p < .05), and FBUT, Meiboscore, MES and MQS were significantly different among different OMGD grades (p < .05). There were significant differences in the detection indexes of OMGD patients in the six regions (p < .05), except LLT (p = .329). According to the Qinling-Huaihe River in China, OMGD patients were divided into the North Group (Shenyang and Beijing) and South Group (Wuhan, Changsha, Chongqing, and Chengdu). There was a significant difference in the detection indexes, except LLT (p = .600), between the two groups (p < .05). FBUT was significantly correlated with the OSDI (r = -0.131; p < .000). Meiboscore and LLT were significantly correlated with the OMGD grade (r = 0.299 and r = 0.106; p < .001). Age, LMS and MQS were significantly correlated with Meiboscore (r = 0.415, r = 0.256 and r = 0.328; p < .001). Conclusions: The prevalence of dry eye was high among OMGD patients. OMGD patients in different age groups may show different gender distributions. The symptoms of patients showed variation among subgroups with different OMGD grades and among different regions.
Subject(s)
Dry Eye Syndromes/epidemiology , Meibomian Gland Dysfunction/epidemiology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Child , China/epidemiology , Cross-Sectional Studies , Dry Eye Syndromes/diagnosis , Female , Humans , Male , Meibomian Gland Dysfunction/diagnosis , Middle Aged , Sex Distribution , Tears/chemistryABSTRACT
PURPOSE: The aim of this study was to analyze the relevant gene mutations in a Chinese family with special phenotypic variants of granular corneal dystrophy type 2 with cornea guttata. METHODS: A total of 11 individuals from the affected family underwent complete ophthalmic examination. Genomic DNA was extracted from peripheral leukocytes of affected and unaffected family members. High-throughput sequencing was performed to screen for mutations in 290 genes associated with inherited ophthalmic diseases. Results were validated by bidirectional Sanger sequencing. RESULTS: An Arg124His (R124H) mutation of the transforming growth factor beta-induced gene was identified in three members of the affected family: the proband (II-1), his mother (I-2), and his son (III-1). The eyes of the proband and his mother had bilateral superficial whitish ring patches with clear centers occupying their central corneas and appeared to be discoid or ring shaped. In addition, specular microscopic examination showed the presence of dark, round bodies. In vivo confocal microscopy showed some hyporeflective round images (cornea guttata), containing occasionally central highlight, in the proband, his mother, and one of his elder sisters. CONCLUSION: We report, for the first time, atypical granular corneal dystrophy type 2 with cornea guttata associated with a single R124H mutation in a Chinese family. Our findings emphasize that genotyping is essential for the accurate diagnosis and classification of granular corneal dystrophy type 2.
Subject(s)
Asian People/genetics , Cornea/pathology , Corneal Dystrophies, Hereditary/genetics , Extracellular Matrix Proteins/genetics , Mutation , Transforming Growth Factor beta/genetics , Adult , Aged , China/epidemiology , Corneal Dystrophies, Hereditary/diagnosis , Corneal Dystrophies, Hereditary/physiopathology , DNA Mutational Analysis , Electrophoresis, Agar Gel , Female , High-Throughput Nucleotide Sequencing , Humans , Male , Microscopy, Confocal , Middle Aged , Pedigree , Phenotype , Polymerase Chain Reaction , Visual Acuity/physiologyABSTRACT
Symblepharon due to chemical burns affects ocular surface health, and there are currently no satisfactory treatments. To improve our understanding of symblepharon, an appropriate animal model is urgently needed. We established a rabbit model of superior conjunctival sac alkaline burn to evaluate symblepharon severity. Alkali burns were induced in rabbits by contacting the superior conjunctival sac with 2 N NaOH-soaked semicircle filter paper (10 mm diameter) for 60 s, 90 s or 120 s. Clinical and histological features were examined, symblepharon severity was evaluated via conjunctival sac depth (grade I - IV) and volume measurements (grade a-d) post-injury at 4 weeks. With increasing alkali burn duration, corneal perforation and symblepharon severity increased. The 60 s group manifested a sub-conjunctiva scar. The 90 s group featured localized adhesion. The 120 s group was characterized by extensive scar hyperplasia and adhesion. The rabbit model exhibited stable and reliable symblepharon following an alkali burn of the superior conjunctival sac. For further research, 90 s is a suitable duration for conjunctival sac burn. The volume measured using conjunctival sac casting was considered when developing a successful evaluation system for symblepharon severity.
Subject(s)
Burns, Chemical/pathology , Conjunctiva/pathology , Eye Burns/pathology , Eyelids/pathology , Lacrimal Apparatus/injuries , Animals , Disease Models, Animal , Female , Lacrimal Apparatus/pathology , Male , Rabbits/injuriesABSTRACT
AIM: To investigate the impact of non-Descemet stripping endothelial keratoplasty (non-DSEK) on graft rejection rate, and its overall procedural effectiveness in patients. METHODS: Non-DSEK was performed on 65 eyes of 64 patients, and the procedural outcomes, including rejection episodes, failure and dislocation of the grafts, best corrected visual acuity (BCVA), endothelial cell density (ECD), and other complications, were analyzed retrospectively. RESULTS: Of the 65 eyes, 63 recovered from bullous keratopathy with a clear cornea. The mean follow-up time was 26.4mo (range, 6-84mo). The mean BCVA improved from 1.70 logMAR preoperatively to 0.54 logMAR at 3mo, 0.46 logMAR at 6mo, and 0.37 logMAR at 1y after surgery. The postoperative donor ECD of the 25 patients who successfully underwent specular microscopic examination was 1918±534 cells/mm2 (range, 637 to 3056 cells/mm2), and the mean endothelial cell loss was 41.9% at 24mo postoperatively. One eye developed secondary glaucoma and required regrafting via penetrating keratoplasty (PKP). Another eye had postoperative graft failure due to rejection at 26mo. Postoperative graft dislocation occurred in eight eyes. All of the eight dislocated grafts were reattached using air reinjection. CONCLUSION: Immunological graft rejection of the donor graft rarely occurs in non-DSEK. Therefore, non-DSEK is a safe, concise, and effective alternative to restore corneal decompensation when the Descemet membrane is disease-free.
ABSTRACT
PURPOSE: To describe a 43-year-old man who presented with a nuclear cataract in the right eye after a previous collamer lens (Visian Implantable Collamer Lens [ICL]; STAAR Surgical, Monrovia, CA) implantation procedure. METHODS: Case report. RESULTS: Before the ICL was removed, femtosecond-laser-assisted capsulotomy, crystalline lens fragmentation, and limbal relaxing incisions were performed sequentially. After explantation of the ICL, the phacoemulsification procedure was performed simultaneously with intraocular lens implantation. CONCLUSIONS: Femtosecond laser-assisted cataract surgery can be done in an eye with previous ICL implantation, but may prove to be more challenging than routine cases without an ICL in situ.